INDOFARMA TBK PT

Business Nature: Manufacturer

Company Profile:

PT Indofarma Tbk is a prominent Indonesian state-owned pharmaceutical company established in 1918. It operates as an integrated healthcare provider engaged in the research, development, production, and distribution of a wide range of pharmaceutical products. Its portfolio includes generic drugs, branded drugs, herbal medicines, medical devices, and health supplements. The company maintains advanced manufacturing facilities that adhere to international quality standards such as Good Manufacturing Practices (GMP). As a subsidiary of the state-owned enterprise Bio Farma, Indofarma plays a critical role in supporting the Indonesian national health system by ensuring the availability and affordability of essential medicines across the country.

INDOFARMA TBK PT manufactures and sells a wide range of pharmaceutical products. These include:

Ethical Drugs:

Antibiotics

Analgesics

Anti-inflammatory drugs

Cardiovascular drugs

Gastrointestinal drugs

Vitamins and supplements

Dermatological preparations

Respiratory drugs

Neurological drugs

Antidiabetic drugs

Antihypertensive drugs

Generic Drugs:

Various generic medications covering multiple therapeutic classes, aiming for affordability and accessibility.

Over-The-Counter (OTC) Drugs:

Cold and flu remedies

Pain relievers

Antacids

Vitamin supplements

Topical creams and ointments

Medical Devices:

Some basic medical devices and diagnostic tools may be part of their portfolio, often related to drug administration or patient monitoring.

Traditional Medicines/Herbal Products:

Certain traditional or herbal-based health products, leveraging Indonesia's rich natural resources.

Consumer Health Products:

Products related to personal care and general wellness.

Raw Materials:

In some instances, they may also be involved in the production or supply of pharmaceutical raw materials.